MYGN Myriad Genetics Q1 earnings miss by 289 percent as EPS decline overshadows flat revenue performance ARCB ArcBest beats Q1 2026 EPS forecasts by 154 percent sending shares up 175 percent in todays session Kinder Morgan Inc KMI Fundamental Analysis for Trending Midstream Energy Equity iShares Core SP SmallCap ETF IJR Positioned to Capture Upside Amid Brewing SmallCap Rotation